Colleen Hall

Most Recent Articles by Colleen Hall

FDA Green-lights First 'Artificial Pancreas' for Type 1 Diabetes

FDA Green-lights First 'Artificial Pancreas' for Type 1 Diabetes

By

Approval was based on a clinical trial that included 123 people with type 1 diabetes who used the MiniMed 670G hybrid closed-loop system for 3 months, after a 2-week period of no use.

Case Study: Hepatitis C Therapy Improved Glycemic Control in Diabetes

Case Study: Hepatitis C Therapy Improved Glycemic Control in Diabetes

By

Control of type 2 diabetes is usually advised prior to hepatitis C therapy in order to increase response rates.

Sign Up for Free e-Newsletters

CME Focus